患有对称帕金森病的患者在亚thalam刺激方面表现不佳
Stefanie Theresa Jost1, Camilla Atwani2, Philipp Alexander Loehrer3
1Department of Neurology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany stefanie.jost@uk-koeln.de haidar.dafsari@uk-koeln.de.
Journal of neurology, neurosurgery, and psychiatry
|March 4, 2026
概括
患有对称帕金森病 (PD) 的患者在脑下深层刺激 (STN-DBS) 后,在日常活动中表现出有限的改善. 与非对称的PD患者相比,对称的PD患者在STN-DBS后没有临床相关的ADL改善的风险更高.
科学领域:
- 神经学 神经学
- 神经外科 神经外科
- 运动障碍 运动障碍
背景情况:
- 运动不对称性在帕金森病 (PD) 中是典型的,但约20%的患者表现出对称的运动迹象.
- 对称的PD与更快的进展和对多巴胺激素治疗的反应较差有关.
- 在下丘脑深层大脑刺激 (STN-DBS) 后,运动对称性对日常生活活动 (ADL) 的影响尚不清楚.
研究的目的:
- 为了研究运动对称性对ADL结果的影响,在PD患者的STN-DBS之后.
- 为了比较ADL在对称PD中的改善与非对称PD患者在STN-DBS后的改善.
- 确定对称的PD是否与STN-DBS后的功能结果较差有关.
主要方法:
- 展望性,国际多中心研究,随访6个月.
- 主要结局:在帕金森病-运动ADL尺度中的结局尺度.
- 对称的PD定义为右到左半身运动得分为1;分析了纵向变化和结果差异.
主要成果:
- 包括200个不对称的PD患者和54个对称的PD患者.
- 对称的PD患者显示稳定的ADL,与不对称的PD患者不同,这些患者的改善程度中等.
- 对称的PD患者没有临床相关的术后ADL改善的风险增加了23.8%.
结论:
- 与不对称的PD相比,STN-DBS在对称的PD中产生更差的ADL结果 (IIb类证据).
- 临床医生应向对称的PD患者告知他们对STN-DBS对ADL无反应的风险增加.
- 对称的PD呈现在规划STN-DBS治疗时需要仔细考虑.
相关概念视频
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K


